Medpace Holdings (MEDP) EBT (2015 - 2026)

Medpace Holdings (MEDP) has reported EBT for 12 consecutive years, with $151.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 21.78% year-over-year to $151.7 million; the trailing twelve-month figure through Jun 2026 stood at $598.9 million (up 20.91% YoY), and the FY2025 full-year result was $542.4 million, up 13.96% from the prior year.
• EBT improved to $151.7 million in Q2 2026 per MEDP's latest filing, from $147.6 million in the prior quarter.
• Across five years, EBT topped out at $156.8 million in Q4 2025 and bottomed at $62.0 million in Q2 2022.
• Historically, EBT has averaged $107.6 million across 5 years, with a median of $111.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: EBT soared 49.61% in 2022, then grew 1.6% in 2023.
• Over 5 years, EBT stood at $73.6 million in 2022, then gained by 23.17% to $90.7 million in 2023, then soared by 47.6% to $133.9 million in 2024, then climbed by 17.14% to $156.8 million in 2025, then slipped by 3.3% to $151.7 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $151.7 million, $147.6 million, and $156.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.